Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphoma.
M J O'Connell(Mayo Clinic in Arizona), M. N. Silverstein(Mayo Clinic in Arizona), Paul P. Carbone(University of Wisconsin Carbone Cancer Center), Risa B. Mann(Boston University), G. J. Johnson(Minneapolis VA Medical Center), Donald P. Harrington(Mayo Clinic in Arizona), Richard S. Neiman(University Medical Center), J H Glick(Mayo Clinic in Arizona), John D. Earle(Mayo Clinic), R H Creech(University of Louisville Hospital)
Cited by 21
Related Papers
Assessment of response to therapy in advanced breast cancer
|British Journal of Cancer|1977|706
Comparison of a Second-Generation Combination Chemotherapeutic Regimen (m-BACOD) with a Standard Regimen (CHOP) for Advanced Diffuse Non-Hodgkin's Lymphoma
|New England Journal of Medicine|1992|326
Assessment of response to therapy in advanced breast cancer
|European Journal of Cancer (1965)|1977|312